N-820

N/A

Report date: 2022/04/25 16:08:11

Base Information

Drug NameN-820
Drug Alias NameN-820
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CD20Interleukin-15 stimulants
TargetsB-lymphocyte antigen CD20Interleukin-15
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunitybio IncNantkwest Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio IncNantkwest Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A